Postoperative intravenous iron: a simple strategy to improve outcomes

The Lancet Haematology

Volumn 3, Issue 9, 2016, Pages e401-e402

  Muñoz, Manuel ^a,b   Auerbach, Michael ^a,b  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC CARBOXYMALTOSE; FERUMOXYTOL; IRON; IRON DEXTRAN; FERRIC ION; MALTOSE;

ANEMIA; DEPRESSION; ERYTHROPOIESIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOPHOSPHATEMIA; INFLAMMATION; INTERVENTION STUDY; NOTE; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PRIORITY JOURNAL; QUALITY OF LIFE ASSESSMENT; RHABDOMYOLYSIS; ANALOGS AND DERIVATIVES; PROSPECTIVE STUDY;

ANEMIA; FERRIC COMPOUNDS; HUMANS; IRON; MALTOSE; PROSPECTIVE STUDIES;

EID: 84991579797     PISSN: None     EISSN: 23523026     Source Type: Journal    
DOI: 10.1016/S2352-3026(16)30083-7     Document Type: Note

References (10)

1. 1 Spahn, DR, Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 113 (2010), 482–495.
2. 2 Leal-Noval, SR, Muñoz-Gómez, M, Jiménez-Sánchez, M, Cayuela, A, Leal-Romero, M, Puppo-Moreno, A, et al. Red blood cell transfusion in non-bleeding critically ill patients with moderate anemia: is there a benefit?. Intensive Care Med 39 (2013), 445–453.
3. 3 Khalafallah, AA, Yan, C, Al-Badri, R, et al. Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial. Lancet Haematol, 2016 published online August 4. http://dx.doi.org/10.1016/S2352-3026(16)30078-3.
4. 4 Bisbe, E, Molto, L, Arroyo, R, Muniesa, JM, Tejero, M, Randomised trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty. Brit J Anaesth 113 (2014), 402–409.
5. 5 Camaschella, C, Iron and hepcidin: a story of recycling and balance. Hematology Am Soc Hematol Educ Program 2013 (2013), 1–8.
6. 6 Beguin, Y, Maertens, J, DePrijck, B, et al. Darbepoietin-alpha and intravenous iron administration aftere autologous hematopoietic stem cell transplantation: A prospective, multicener, randomized trial. Am J Hematol 88 (2013), 940–946.
7. 7 Muñoz, M, Gómez-Ramirez, S, Cuenca, J, et al. Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion 54 (2014), 289–299.
8. 8 Kautz, L, Jung, G, Valore, EV, et al. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nature Genetics 46 (2014), 678–684.
9. 9 Macdougall, IC, Bock, AH, Carrera, F, Eckardt, KU, Gaillard, C, Van Wyck, D, et al., FIND-CKD Study Investigators. FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia. Nephrol Dial Transplant 29 (2014), 2075–2084.
10. 10 Avni, T, Bieber, A, Grossman, A, Green, H, Leibovici, L, Gafter-Gvili, A, The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc 90 (2015), 12–23.